| |
| HOUSE OF COMMONS |
|
CHAMBRE DES COMMUNES |
| 2nd Session, 40th Parliament |
|
2e session, 40e législature |
|
|
|
| NOTICE OF MEETING |
|
AVIS DE CONVOCATION |
| |
| Standing Committee on Health |
|
Comité permanent de la santé |
| |
| AMENDED |
|
MODIFIÉ |
| |
| Meeting No. 39 | | Séance no 39 |
| Monday, October 26, 2009 | | Le lundi 26 octobre 2009 |
| 3:30 p.m. to 5:30 p.m. | | 15 h 30 à 17 h 30 |
| Room 214, Wellington Building |
|
Pièce 214, édifice Wellington |
| (613-996-7139) |
|
(613-996-7139) |
|
| |
|
|
|
| |
| Orders of the Day |
|
Ordre du jour |
| |
| |
| 3:30 p.m. to 5:30 p.m. | | 15 h 30 à 17 h 30 |
| |
| Video Recording | | Enregistrement vidéo |
| |
| H1N1 Preparedness and Response | | Préparation et réponse au virus H1N1 |
| |
| Witnesses | | Témoins |
| |
| Department of Health | | ministère de la Santé |
| |
| Elwyn Griffiths, Director General | | Elwyn Griffiths, directeur général |
| |
| GlaxoSmithKline Canada | | GlaxoSmithKline Canada |
| |
| Paul N. Lucas, President and Chief Executive Officer | | Paul N. Lucas, président et chef de la direction |
| |
| Public Health Agency of Canada | | Agence de la santé publique du Canada |
| |
| David Butler-Jones, Chief Public Health Officer | | David Butler-Jones, administrateur en chef de la santé publique |
| |
Robert Pless, Program Director Canadian Field Epidemiology Program | | Robert Pless, directeur de programme Programme canadien d'épidémiologie de terrain |
| |
| Sanofi Pasteur | | Sanofi Pasteur |
| |
Rob Van Exan, Director Immunization Policy | | Rob Van Exan, directeur Politique d'immunisation |
| |
| Videoconference - Vancouver | | Vidéoconférence - Vancouver |
| |
| Vaccination Risk Awareness Network Inc. | | Vaccination Risk Awareness Network inc. |
| |
| Susan Fletcher, Researcher and Board Member | | Susan Fletcher, recherchiste et membre de la commission |
| |
| |
| La greffière du Comité |
| Christine Holke David (613-995-4108) |
| Clerk of the Committee |
| |
| 2009/10/26 9:30 a.m. |
|
2009/10/26 9 h 30 |